2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Epygenix: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome Clemizole HCl, Placebo - Lennox Gastaut Syndrome | Phase 3 | Recruiting | Epygenix | 260 | 2025-04-09 | 2026-10-09 |
| A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome Clemizole HCl, Placebo - Dravet Syndrome | Phase 3 | Recruiting | Epygenix | 150 | 2020-09-15 | 2026-10-29 |
Seizures (2) · Epilepsies, Myoclonic (1) · Lennox Gastaut Syndrome (1)
China (2) · Hungary (2) · India (2) · Poland (2) · Spain (2) · United States (2) · Argentina (1) · Brazil (1) · Canada (1) · Georgia (1) · Italy (1) · Romania (1) · Serbia (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Amit Ray, MD (2)